Trial Profile
Safety and efficacy of Tenofovir disoproxil fumarate (TDF) as a switch from long-term exposure to Adefovir (ADV) in real life setting patients with chronic hepatitis B.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Dec 2015
Price :
$35
*
At a glance
- Drugs Tenofovir disoproxil fumarate (Primary)
- Indications Hepatitis B
- Focus Adverse reactions; Therapeutic Use
- 17 Dec 2015 New trial record